chr11-125981160-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001378964.1(CDON):​c.3165T>C​(p.Asn1055Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.272 in 1,613,738 control chromosomes in the GnomAD database, including 62,723 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.31 ( 8301 hom., cov: 32)
Exomes 𝑓: 0.27 ( 54422 hom. )

Consequence

CDON
NM_001378964.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -1.91

Publications

20 publications found
Variant links:
Genes affected
CDON (HGNC:17104): (cell adhesion associated, oncogene regulated) This gene encodes a cell surface receptor that is a member of the immunoglobulin superfamily. The encoded protein contains three fibronectin type III domains and five immunoglobulin-like C2-type domains. This protein is a member of a cell-surface receptor complex that mediates cell-cell interactions between muscle precursor cells and positively regulates myogenesis. [provided by RefSeq, Aug 2011]
CDON Gene-Disease associations (from GenCC):
  • holoprosencephaly 11
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Illumina
  • pituitary stalk interruption syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 11-125981160-A-G is Benign according to our data. Variant chr11-125981160-A-G is described in ClinVar as Benign. ClinVar VariationId is 260792.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.91 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.453 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDONNM_001378964.1 linkc.3165T>C p.Asn1055Asn synonymous_variant Exon 17 of 20 ENST00000531738.6 NP_001365893.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDONENST00000531738.6 linkc.3165T>C p.Asn1055Asn synonymous_variant Exon 17 of 20 1 NM_001378964.1 ENSP00000432901.2 Q4KMG0-2E9PN78

Frequencies

GnomAD3 genomes
AF:
0.315
AC:
47772
AN:
151872
Hom.:
8277
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.459
Gnomad AMI
AF:
0.455
Gnomad AMR
AF:
0.244
Gnomad ASJ
AF:
0.337
Gnomad EAS
AF:
0.0794
Gnomad SAS
AF:
0.210
Gnomad FIN
AF:
0.289
Gnomad MID
AF:
0.244
Gnomad NFE
AF:
0.271
Gnomad OTH
AF:
0.272
GnomAD2 exomes
AF:
0.256
AC:
64400
AN:
251404
AF XY:
0.252
show subpopulations
Gnomad AFR exome
AF:
0.467
Gnomad AMR exome
AF:
0.203
Gnomad ASJ exome
AF:
0.335
Gnomad EAS exome
AF:
0.0800
Gnomad FIN exome
AF:
0.302
Gnomad NFE exome
AF:
0.266
Gnomad OTH exome
AF:
0.251
GnomAD4 exome
AF:
0.267
AC:
390877
AN:
1461748
Hom.:
54422
Cov.:
37
AF XY:
0.265
AC XY:
192727
AN XY:
727180
show subpopulations
African (AFR)
AF:
0.466
AC:
15597
AN:
33478
American (AMR)
AF:
0.209
AC:
9353
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.334
AC:
8740
AN:
26130
East Asian (EAS)
AF:
0.0795
AC:
3155
AN:
39700
South Asian (SAS)
AF:
0.222
AC:
19183
AN:
86258
European-Finnish (FIN)
AF:
0.299
AC:
15992
AN:
53416
Middle Eastern (MID)
AF:
0.230
AC:
1328
AN:
5766
European-Non Finnish (NFE)
AF:
0.271
AC:
301609
AN:
1111886
Other (OTH)
AF:
0.264
AC:
15920
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
17201
34402
51602
68803
86004
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10150
20300
30450
40600
50750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.315
AC:
47849
AN:
151990
Hom.:
8301
Cov.:
32
AF XY:
0.310
AC XY:
23040
AN XY:
74286
show subpopulations
African (AFR)
AF:
0.459
AC:
19011
AN:
41422
American (AMR)
AF:
0.244
AC:
3736
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.337
AC:
1169
AN:
3468
East Asian (EAS)
AF:
0.0790
AC:
409
AN:
5176
South Asian (SAS)
AF:
0.211
AC:
1014
AN:
4814
European-Finnish (FIN)
AF:
0.289
AC:
3050
AN:
10560
Middle Eastern (MID)
AF:
0.252
AC:
74
AN:
294
European-Non Finnish (NFE)
AF:
0.271
AC:
18392
AN:
67950
Other (OTH)
AF:
0.275
AC:
580
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1610
3220
4831
6441
8051
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
448
896
1344
1792
2240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.268
Hom.:
3387
Bravo
AF:
0.318
Asia WGS
AF:
0.206
AC:
717
AN:
3478
EpiCase
AF:
0.256
EpiControl
AF:
0.256

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Holoprosencephaly 11 Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.022
DANN
Benign
0.31
PhyloP100
-1.9
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs564214; hg19: chr11-125851055; COSMIC: COSV54998321; API